Works matching DE "PROTEASOME inhibitors"
Results: 1119
Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities: transcriptomic and epigenetic profiling.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-87442-5
- By:
- Publication type:
- Article
More than meets the eye: Nocardia farcinica, Candida dubliniensis and Aspergillus spp. co-infection in a patient with multiple myeloma treated with multiple treatment regimens.
- Published in:
- BMC Infectious Diseases, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12879-024-10387-z
- By:
- Publication type:
- Article
Canagliflozin differentially modulates carfilzomib-induced endoplasmic reticulum stress in multiple myeloma and endothelial cells.
- Published in:
- Archives of Toxicology, 2025, v. 99, n. 2, p. 729, doi. 10.1007/s00204-024-03913-0
- By:
- Publication type:
- Article
Conformational switching of the 26S proteasome enables substrate degradation.
- Published in:
- Nature Structural & Molecular Biology, 2013, v. 20, n. 7, p. 781, doi. 10.1038/nsmb.2616
- By:
- Publication type:
- Article
Current Treatment Options for Relapsed/Refractory Multiple Myeloma.
- Published in:
- Current Medical Literature: Leukemia & Lymphoma, 2014, v. 22, n. 4, p. 107
- By:
- Publication type:
- Article
E3 ubiquitin ligase Cullin4B mediated polyubiquitination of p53 for its degradation.
- Published in:
- Molecular & Cellular Biochemistry, 2014, v. 390, n. 1/2, p. 93, doi. 10.1007/s11010-014-1960-3
- By:
- Publication type:
- Article
Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.
- Published in:
- Molecular & Cellular Biochemistry, 2014, v. 385, n. 1/2, p. 265, doi. 10.1007/s11010-013-1835-z
- By:
- Publication type:
- Article
Inhibition of autophagy by autophagic inhibitors enhances apoptosis induced by bortezomib in non-small cell lung cancer cells.
- Published in:
- Biotechnology Letters, 2014, v. 36, n. 6, p. 1171, doi. 10.1007/s10529-014-1470-0
- By:
- Publication type:
- Article
Structural features and binding free energies for non-covalent inhibitors interacting with immunoproteasome by molecular modeling and dynamics simulations.
- Published in:
- Theoretical Chemistry Accounts: Theory, Computation, & Modeling, 2012, v. 131, n. 4, p. 1, doi. 10.1007/s00214-012-1203-1
- By:
- Publication type:
- Article
Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.
- Published in:
- Basic Research in Cardiology, 2013, v. 108, n. 3, p. 1, doi. 10.1007/s00395-013-0349-x
- By:
- Publication type:
- Article
Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
- Published in:
- Acta Neuropathologica, 2012, v. 124, n. 1, p. 51, doi. 10.1007/s00401-012-0977-5
- By:
- Publication type:
- Article
N-(Hetero)aryl-2-imidazolines: an emerging privileged motif for contemporary drug design.
- Published in:
- Chemistry of Heterocyclic Compounds, 2017, v. 53, n. 3, p. 240, doi. 10.1007/s10593-017-2047-3
- By:
- Publication type:
- Article
Pathway-structured predictive modeling for multi-level drug response in multiple myeloma.
- Published in:
- Bioinformatics, 2018, v. 34, n. 21, p. 3609, doi. 10.1093/bioinformatics/bty436
- By:
- Publication type:
- Article
Ixazomib-induced Sweet's syndrome: A case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Dichlorodiphenyldichloroethylene exposure reduces r-GCS via suppressed Nrf2 in HepG2 cells.
- Published in:
- Environmental Toxicology, 2016, v. 31, n. 3, p. 350, doi. 10.1002/tox.22049
- By:
- Publication type:
- Article
Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience.
- Published in:
- Turkish Journal of Medical Sciences, 2018, v. 48, n. 1, p. 80, doi. 10.3906/sag-1611-97
- By:
- Publication type:
- Article
The combined effects of proteasome inhibitor bortezomib with topoisomerase I and II inhibitors on topoisomerase enzymes.
- Published in:
- Turkish Journal of Medical Sciences, 2016, v. 46, n. 6, p. 1882, doi. 10.3906/sag-1511-184
- By:
- Publication type:
- Article
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2017, v. 32, n. 1, p. 865, doi. 10.1080/14756366.2017.1334649
- By:
- Publication type:
- Article
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2016, v. 31, n. 3, p. 456, doi. 10.3109/14756366.2015.1037749
- By:
- Publication type:
- Article
Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Attachment of the Oxadiazole Ring to Tetrazolecontaining Proteasome Inhibitor Increases Cell Death in ER+ Breast Cancer Cells.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
多发性骨髓瘤患者硼替佐米治疗相关带状疱疹发病机理 及预防策略研究进展
- Published in:
- Progress in Modern Biomedicine, 2019, v. 19, n. 13, p. 2592, doi. 10.13241/j.cnki.pmb.2019.13.044
- By:
- Publication type:
- Article
Zastosowanie oksykodonu/naloksonu w terapii leczenia bólu u pacjenta ze szpiczakiem plazmocytowym.
- Published in:
- Anaesthesiology & Rescue Medicine / Anestezjologia i Ratownictwo, 2016, v. 10, n. 4, p. 382
- By:
- Publication type:
- Article
Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors.
- Published in:
- Scientifica, 2014, p. 1, doi. 10.1155/2014/596528
- By:
- Publication type:
- Article
Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43121-x
- By:
- Publication type:
- Article
Regulation of TRIB1 abundance in hepatocyte models in response to proteasome inhibition.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36512-7
- By:
- Publication type:
- Article
Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1351565
- By:
- Publication type:
- Article
Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer Cells.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00476
- By:
- Publication type:
- Article
Successful treatment of refractory pure red cell aplasia with bortezomib after allogeneic haematopoietic cell transplantation in a patient with alpha-beta subcutaneous panniculitis-like T cell lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2021, v. 11, p. 11, doi. 10.2147/BLCTT.S245191
- By:
- Publication type:
- Article
Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2017, p. 53, doi. 10.2147/BLCTT.S82444
- By:
- Publication type:
- Article
Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2013, v. 3, p. 41, doi. 10.2147/BLCTT.S31867
- By:
- Publication type:
- Article
Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review.
- Published in:
- Case Reports in Hematology, 2020, p. 1, doi. 10.1155/2020/4360926
- By:
- Publication type:
- Article
A Rare Case of Ixazomib-Induced Cutaneous Necrotizing Vasculitis in a Patient with Relapsed Myeloma.
- Published in:
- Case Reports in Hematology, 2019, p. 1, doi. 10.1155/2019/6061484
- By:
- Publication type:
- Article
The First Autopsy Case of Fatal Acute Cardiac Failure after Administration of Carfilzomib in a Patient with Multiple Myeloma.
- Published in:
- Case Reports in Hematology, 2019, p. 1, doi. 10.1155/2019/1816287
- By:
- Publication type:
- Article
Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib.
- Published in:
- Case Reports in Hematology, 2018, p. 1, doi. 10.1155/2018/7063145
- By:
- Publication type:
- Article
Successful treatment of refractory systemic lupus erythematosus using proteasome inhibitor bortezomib followed by belimumab: description of two cases.
- Published in:
- Lupus, 2017, v. 26, n. 12, p. 1333, doi. 10.1177/0961203317691371
- By:
- Publication type:
- Article
Manganese activates caspase-9-dependent apoptosis in human bronchial epithelial cells.
- Published in:
- Human & Experimental Toxicology, 2013, v. 32, n. 11, p. 1155, doi. 10.1177/0960327112470272
- By:
- Publication type:
- Article
Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
- Published in:
- Human & Experimental Toxicology, 2011, v. 30, n. 12, p. 1945, doi. 10.1177/0960327111403173
- By:
- Publication type:
- Article
Bortezomib: Safety and Efficacy in the Treatment of Multiple Myeloma.
- Published in:
- Clinical Medicine Reviews in Oncology, 2010, n. 2, p. 293, doi. 10.4137/CMRO.S1631
- By:
- Publication type:
- Article
Allosteric regulation of the 20S proteasome by the Catalytic Core Regulators (CCRs) family.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38404-w
- By:
- Publication type:
- Article
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37013-x
- By:
- Publication type:
- Article
Monoubiquitination joins polyubiquitination as an esteemed proteasomal targeting signal.
- Published in:
- BioEssays, 2017, v. 39, n. 6, p. n/a, doi. 10.1002/bies.201700027
- By:
- Publication type:
- Article
Proteasome subunit beta type 1 interacts directly with Rheb and regulates the cell cycle in Cashmere goat fetal fibroblasts.
- Published in:
- Animal Cells & Systems, 2017, v. 21, n. 5, p. 307, doi. 10.1080/19768354.2017.1371072
- By:
- Publication type:
- Article
New Rising Infection: Human Herpesvirus 6 Is Frequent in Myeloma Patients Undergoing Autologous Stem Cell Transplantation after Induction Therapy with Bortezomib.
- Published in:
- Bone Marrow Research, 2012, p. 1, doi. 10.1155/2012/409765
- By:
- Publication type:
- Article
Biology -- Therapy.
- Published in:
- 2013
- Publication type:
- Opinion
Paradoxical inhibition of cellular protein expression by proteasome inhibitors.
- Published in:
- Biomolecular Concepts, 2012, v. 3, n. 6, p. 593, doi. 10.1515/bmc-2012-0029
- By:
- Publication type:
- Article
A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 8, p. 1176, doi. 10.3390/v16081176
- By:
- Publication type:
- Article
Bortezomib induced reversible left ventricular systolic dysfunction: A case report and review of literature.
- Published in:
- British Journal of Medical Practitioners, 2013, v. 6, n. 4, p. 20
- By:
- Publication type:
- Article
Flavanoids as Potential NEDD-4 Inhibitors: In Silico Discovery Using Molecular Docking and ADME Studies.
- Published in:
- Interdisciplinary Sciences: Computational Life Sciences, 2017, v. 9, n. 1, p. 56, doi. 10.1007/s12539-016-0167-6
- By:
- Publication type:
- Article